2023 annual financial data
BriaCell Therapeutics 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -31,080,690 USD and net income was -27,114,354 USD.
Operating cash flow was -31,891,100 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,080,690 USD
- Net income
- -27,114,354 USD
- Operating cash flow
- -31,891,100 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all BriaCell Therapeutics financial years